VGXI Selected for RRPV Membership to Advance Vaccine Manufacturing
VGXI, Inc., a contract developer and manufacturer (CDMO) specialising in nucleic acid biopharmaceuticals, has been selected to join the Rapid Response Partnership Vehicle (RRPV). This…